Back to competency map

Clinical competency

Subpsychedelic 5-MeO-DMT administration

Administers repeated sublingual microdoses of 5-MeO-DMT in a controlled clinical trial setting. Must follow the assigned dose schedule and maintain blinding across active and placebo conditions.

Primary clinical guidelineModern clinical

Looking for something specific? Ask Blossom

Guidelines

1

Courses

0

Providers

0

Protocols

2

Classification

Care stages

Dosing

Protocol families

5-MeO-DMTDMT / Ayahuasca

Source quality

Protocol paper

Linked sources

The guidelines, courses, and providers that evidence this competency. Full lists are a Blossom Pro feature.

Linked guidelines (1)

  • Safety and tolerability of multiple sublingual microdoses of 5-MeO-DMT in adults with moderate symptoms of depression and/or anxiety: a randomized, double-blind, placebo-controlled study

    5-MeO-DMTEvidence score: 90
    Bistue Millón et al., 2025Source PDF

Unlock every linked source

See all linked guidelines, courses, and providers behind this competency, plus the full competency graph.

Unlock full depth